BACKGROUND: Single point mutations in the genes coding for factor V [G1691A; Leiden], prothrombin [PRT; G20210A], and methylenetetrahydrofolate reductase [MTHFR, C677T] were shown to be major inherited predisposing factors for venous thromboembolism. However, their contribution in the development of coronary artery disease [CAD] remains controversial. The aim of the study was to examine the association of these mutations in CAD. METHODS: A total of 96 patients with angiographically-demonstrated CAD [mean age 55.3 +/- 11.3], and 404 healthy subjects [mean age 50.7 +/- 8.9] were recruited into the study. Fasting plasma homocysteine was determined by HPLC, and genotype analysis was assessed by PCR-RFLP. RESULTS: The carrier frequency of factor V-Leiden (14.6% vs. 15.1%, p = 0.617) and PRT G20210A (3.1% vs. 3.0%; p = 0.936) were similar between patients and controls, respectively. In contrast, the frequency of the MTHFR variant C677T was 71.9% among patients compared with 45.5% in controls (p < 0.001), of which the T/T genotype was significantly higher among patients (31.3%) than controls (4.5%; p < 0.001). Significantly higher homocysteine levels were seen among T/T genotype in both groups compared to non-T/T carriers (p < 0.05), and among patients compared with controls (18.47 +/- 3.73 micromol/L vs. 16.28 +/- 4.16 micromol/L). In addition, the coexistence of MTHFR C677T with FV-Leiden was seen in 10.4% of CAD patients compared 6.9% of controls (p = 0.001). CONCLUSION: While results from this study clearly demonstrate a strong association of hyperhomocysteinemia and homozygosity of the MTHFR C677T, but not FV-Leiden or PRT G20210A, mutations with confirmed CAD, they also suggest a potential role for factor V-Leiden in MTHFR C677T carriers.
BACKGROUND: Single point mutations in the genes coding for factor V [G1691A; Leiden], prothrombin [PRT; G20210A], and methylenetetrahydrofolate reductase [MTHFR, C677T] were shown to be major inherited predisposing factors for venous thromboembolism. However, their contribution in the development of coronary artery disease [CAD] remains controversial. The aim of the study was to examine the association of these mutations in CAD. METHODS: A total of 96 patients with angiographically-demonstrated CAD [mean age 55.3 +/- 11.3], and 404 healthy subjects [mean age 50.7 +/- 8.9] were recruited into the study. Fasting plasma homocysteine was determined by HPLC, and genotype analysis was assessed by PCR-RFLP. RESULTS: The carrier frequency of factor V-Leiden (14.6% vs. 15.1%, p = 0.617) and PRT G20210A (3.1% vs. 3.0%; p = 0.936) were similar between patients and controls, respectively. In contrast, the frequency of the MTHFR variant C677T was 71.9% among patients compared with 45.5% in controls (p < 0.001), of which the T/T genotype was significantly higher among patients (31.3%) than controls (4.5%; p < 0.001). Significantly higher homocysteine levels were seen among T/T genotype in both groups compared to non-T/T carriers (p < 0.05), and among patients compared with controls (18.47 +/- 3.73 micromol/L vs. 16.28 +/- 4.16 micromol/L). In addition, the coexistence of MTHFRC677T with FV-Leiden was seen in 10.4% of CAD patients compared 6.9% of controls (p = 0.001). CONCLUSION: While results from this study clearly demonstrate a strong association of hyperhomocysteinemia and homozygosity of the MTHFRC677T, but not FV-Leiden or PRT G20210A, mutations with confirmed CAD, they also suggest a potential role for factor V-Leiden in MTHFRC677T carriers.
Authors: N Irani-Hakime; H Tamim; G Elias; S Choueiry; R Kreidy; J L Daccache; W Y Almawi Journal: J Thromb Thrombolysis Date: 2001-04 Impact factor: 2.300
Authors: F Burzotta; K Paciaroni; V De Stefano; P Chiusolo; A Manzoli; I Casorelli; A M Leone; E Rossi; G Leone; A Maseri; F Andreotti Journal: Eur Heart J Date: 2002-01 Impact factor: 29.983
Authors: M L Varela; Y P Adamczuk; R R Forastiero; M E Martinuzzo; G S Cerrato; G Pombo; L O Carreras Journal: Thromb Res Date: 2001-12-01 Impact factor: 3.944
Authors: K S Woo; P Chook; Y I Lolin; A S Cheung; L T Chan; Y Y Sun; J E Sanderson; C Metreweli; D S Celermajer Journal: Circulation Date: 1997-10-21 Impact factor: 29.690
Authors: Bea C Tanis; Daisy G M Bloemenkamp; Maurice A A J van den Bosch; Jeanet M Kemmeren; Ale Algra; Yolanda van de Graaf; Frits R Rosendaal Journal: Br J Haematol Date: 2003-08 Impact factor: 6.998
Authors: Wassim Y Almawi; Hala Tamim; Raghid Kreidy; Georgina Timson; Elias Rahal; Malak Nabulsi; Ramzi R Finan; Noha Irani-Hakime Journal: J Thromb Thrombolysis Date: 2005-06 Impact factor: 2.300
Authors: Erika R F Siqueira; Cláudia P M S Oliveira; Maria T C Muniz; Filipe Silva; Leila M M B Pereira; Flair J Carrilho Journal: Nutr J Date: 2011-08-19 Impact factor: 3.271